UBS Group’s Advent/Claymore Enhanced Gth & F LCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-32,316
| Closed | -$250K | – | 8555 |
|
|
2018
Q2 | $250K | Buy |
32,316
+1,441
| +5% | +$11.4K | ﹤0.01% | 4794 |
|
|
2018
Q1 | $245K | Sell |
30,875
-12,364
| -29% | -$102K | ﹤0.01% | 4652 |
|
|
2017
Q4 | $361K | Buy |
43,239
+2,346
| +6% | +$19.9K | ﹤0.01% | 4517 |
|
|
2017
Q3 | $352K | Sell |
40,893
-21,456
| -34% | -$184K | ﹤0.01% | 4476 |
|
|
2017
Q2 | $546K | Buy |
62,349
+1,894
| +3% | +$16.5K | ﹤0.01% | 4058 |
|
|
2017
Q1 | $510K | Sell |
60,455
-1,215
| -2% | -$10.3K | ﹤0.01% | 4031 |
|
|
2016
Q4 | $511K | Buy |
61,670
+14,386
| +30% | +$117K | ﹤0.01% | 4105 |
|
|
2016
Q3 | $395K | Sell |
47,284
-558
| -1% | -$4.68K | ﹤0.01% | 4074 |
|
|
2016
Q2 | $392K | Buy |
47,842
+741
| +2% | +$6.13K | ﹤0.01% | 4083 |
|
|
2016
Q1 | $387K | Sell |
47,101
-2,269
| -5% | -$17.8K | ﹤0.01% | 3966 |
|
|
2015
Q4 | $409K | Sell |
49,370
-6,433
| -12% | -$54.5K | ﹤0.01% | 4118 |
|
|
2015
Q3 | $457K | Buy |
55,803
+54,382
| +3,827% | +$476K | ﹤0.01% | 3968 |
|
|
2015
Q2 | $13K | Buy |
1,421
+30
| +2% | +$285 | ﹤0.01% | 7281 |
|
|
2015
Q1 | $13K | Sell |
1,391
-558
| -29% | -$5.16K | ﹤0.01% | 7457 |
|
|
2014
Q4 | $17K | Buy |
+1,949
| New | +$17.9K | ﹤0.01% | 7912 |
|
UBS Group's LCM Position: Q3 2018 in Review
UBS Group sold out of Advent/Claymore Enhanced Gth & F (LCM) in Q3 2018, closing a stake of 32,316 shares — an estimated $250K sold.
UBS Group first reported a position in LCM in Q4 2014 and held it in 15 quarters. The position peaked at $546K in Q2 2017. 0 funds tracked by Wall St. Rank hold LCM as of Q3 2018.
- UBS Group reported no remaining Advent/Claymore Enhanced Gth & F position as of Q3 2018 after selling out during the quarter.
- UBS Group sold 32,316 Advent/Claymore Enhanced Gth & F shares in Q3 2018, an estimated $250K.
- UBS Group first reported a position in Advent/Claymore Enhanced Gth & F in Q4 2014 and held it in 15 quarters.
- UBS Group's Advent/Claymore Enhanced Gth & F position peaked at $546K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Advent/Claymore Enhanced Gth & F as of Q3 2018.
Based on UBS Group's 13F filing for Q3 2018, filed 14 Nov 2018.